Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2017 Filed Apr 28, 2017 15:30 UTC |
SNODGRASS H. RALPHDirector · PRES./CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000677 · form4-04282017_120408.xml · derivative · entry 1 SNODGRASS H. RALPH · CIK 0001415876 · Director · PRES./CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 19:31 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000679 · form4-04282017_120423.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 19:33 UTC |
DOTSON JERROLD DUANECFO AND SECRETARY
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000682 · form4-04282017_120403.xml · derivative · entry 1 DOTSON JERROLD DUANE · CIK 0001388853 · CFO AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 19:32 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000681 · form4-04282017_120426.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 19:32 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000680 · form4-04282017_120454.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 20:30 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007384 · form4-11102016_081106.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 20:30 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007383 · form4-11102016_081102.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 20:30 UTC |
SNODGRASS H. RALPHDirector · PRES./CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007387 · form4-11102016_081120.xml · derivative · entry 1 SNODGRASS H. RALPH · CIK 0001415876 · Director · PRES./CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 11, 2016 01:30 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007385 · form4-11102016_081111.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 11, 2016 01:30 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007386 · form4-11102016_081115.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 11, 2016 01:30 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007388 · form4-11102016_081124.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 11, 2016 01:30 UTC |
DOTSON JERROLD DUANECFO AND SECRETARY
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-16-007389 · form4-11102016_081129.xml · derivative · entry 1 DOTSON JERROLD DUANE · CIK 0001388853 · CFO AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: Options vest monthly over a period of three years commencing November 9, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.